| Review: |
This edition of the reference book includes new as well as rewritten and updated chapters. It follows the same format as the last edition. In the first half of the book there are chapters on radioactivity, radioactive decay, radiation detection and measurement, radiation protection and risk, radiation safety, US licensing and regulatory control, radionuclide production, radiopharmaceuticals for positron emission tomography, and the nuclear pharmacy. The second half of the book coves the diagnosis and their therapeutic use of radiopharmaceuticals with chapters on specific parts of the body: the brain, thyroids, heart, lungs, liver, spleen and gastronomic tract, kidneys and bones. These chapters relate the physiological processes that are important to the localization of imaging agents and describe the development of the radiopharmaceuticals that are used to study the particular organ system. The focus is on the current agents of choice, their biological properties, and their mechanisms of localization. Each chapter ends with a discussion of nuclear medicine procedures, including the rationale, pharmaceutical choices, and interpretation of results. The last there chapters describe monoclonal antibodies for diagnostic use, in vivo function studies, and therapeutic pharmaceuticals. |